CD38 Antibody Daratumumab for the Treatment of Chronic Active Antibody-mediated Kidney Allograft Rejection-Reference-Cited by-同舟云学术

CD38 Antibody Daratumumab for the Treatment of Chronic Active Antibody-mediated Kidney Allograft Rejection

Published:2021-01-26 Issue:2 Volume:105 Page:451-457
ISSN:0041-1337
Container-title:Transplantation
language:en
Short-container-title:

Author:

Doberer Konstantin,Kläger Johannes,Gualdoni Guido A.,Mayer Katharina A.,Eskandary Farsad,Farkash Evan A.,Agis Hermine,Reiter Thomas,Reindl-Schwaighofer Roman,Wahrmann Markus,Cohen Gerald,Haslacher Helmuth,Bond Gregor,Simonitsch-Klupp Ingrid,Halloran Philip F.,Böhmig Georg A.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Transplantation

Reference25 articles.

1. Antibody-mediated rejection of solid-organ allografts.;Loupy;N Engl J Med,2018

2. The therapeutic challenge of late antibody-mediated kidney allograft rejection.;Böhmig;Transpl Int,2019

3. A randomized trial of bortezomib in late antibody-mediated kidney transplant rejection.;Eskandary;J Am Soc Nephrol,2018

4. Treatment of chronic antibody mediated rejection with intravenous immunoglobulins and rituximab: a multicenter, prospective, randomized, double-blind clinical trial.;Moreso;Am J Transplant,2018

5. Eculizumab therapy for chronic antibody-mediated injury in kidney transplant recipients: a pilot randomized controlled trial.;Kulkarni;Am J Transplant,2017

Cited by 73 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Expanding horizons in cancer therapy by immunoconjugates targeting tumor microenvironments;Critical Reviews in Oncology/Hematology;2024-09

2. Perspective for Donor-Derived Cell-Free DNA in Antibody-Mediated Rejection After Kidney Transplantation: Defining Context of Use and Clinical Implications;Transplant International;2024-08-12

3. Advancing kidney transplant outcomes: the role of urinary proteomics in graft function monitoring and rejection detection;Expert Review of Proteomics;2024-08-02

4. Donor-Derived Cell-Free DNA as a Companion Biomarker for AMR Treatment With Daratumumab: Case Series;Transplant International;2024-08-01

5. Targeting CD38 in Subclinical Antibody-mediated Rejection in HLA-incompatible Kidney Transplantation: A Case Report;Transplantation Direct;2024-07-18